Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0000899243-22-028246 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-10 | 2022-08-08 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale+OE | $292.54 | -1,304 | 36.5K | -3% | -$381.5K |
| D | 2022-08-10 | 2022-08-08 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $187.53 | +1,304 | 37.4K | +4% | +$244.5K |
| D | 2022-08-10 | 2022-08-08 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $0.00 | -1,304 | 2,607 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-08 | S | D | 222 | $290.32 | 37,159 | D | — | — | (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $290.32 (range $290.05 to $290.64). |
| 2 | Common | Common Stock | 2022-08-08 | M | A | 1,304 | $187.53 | 37,381 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-08 | S | D | 302 | $293.99 | 36,223 | D | — | — | (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $293.99 (range $293.58 to $294.26). |
| 4 | Common | Common Stock | 2022-08-08 | S | D | 424 | $291.53 | 36,735 | D | — | — | (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $291.53 (range $291.06 to $291.91). |
| 5 | Common | Common Stock | 2022-08-08 | S | D | 146 | $295.14 | 36,077 | D | — | — | (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $295.14 (range $294.74 to $295.53). |
| 6 | Common | Common Stock | 2022-08-08 | S | D | 210 | $293.02 | 36,525 | D | — | — | (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $293.02 (range $292.41 to $293.36). |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-08-08 | M | D | 1,304 | $0.00 | 2,607 | D | $187.53 · — to 2029-02-05 | 1,304 Common Stock | (F8) The option vests in 16 quarterly installments from 2/6/2019. |